Leaders From South Korea’s Cancer Center Travel To Ohio State To Learn Best Practices In Cancer Research And Care  

COLUMBUS, Ohio – Leaders from Samsung Cancer Center, located in Seoul, South Korea, traveled 7,000 miles, flying for more than a day and crossing 14 hours in time zones, just to have the opportunity to meet this week with leaders from the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) and  learn best practices in cancer research and patient care.

 

While these leaders could have gone anywhere, they chose Ohio State as one of three cancer centers in the United States to tour. Ohio State is unique in the structure, support and capabilities in cancer. As the only National Cancer Institute-designated comprehensive cancer center on the campus of the nation’s largest public university with a freestanding cancer hospital, the OSUCCC-James brings the depth and breadth of the University to bear on cancer research in ways to prevent, detect, treat and cure cancers. As such, the South Korean delegation wanted to learn how cancer research is supported, managed and funded at Ohio State. They also wanted to learn how discoveries are then translated into cancer treatments for patients at The James. 

 

The international guests also toured the construction site for the new Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Critical Care Tower, a state-of-the-art, 20-floor, 276-bed cancer hospital that will open in 2014.  The delegation also toured The Stefanie Spielman Comprehensive Breast Center, which opened last year and is the only one of its kind in the Midwest to offer the full continuum of breast cancer care, from prevention and screening through detection, diagnosis and treatment. The breast center is home to some of the nation’s leading breast cancer researchers and physicians, all singularly focused on preventing, detecting, treating and curing breast cancer.

 

Dr. Michael Caligiuri, Director of Ohio State’s Comprehensive Cancer Center and CEO of The James Cancer Hospital and Solove Research Institute, and other leaders throughout the cancer program presented to the delegation of six physicians, researchers and administrators from the Samsung Cancer Center.

 

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 210-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report. 

# # #

Contact: Gina Bericchia, Medical Center Public Affairs and Media Relations, 614-293-3737, Gina.Bericchia@osumc.edu